Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center

Paul K. Sue, Nora Pisanic, Christopher D. Heaney, Michael Forman, Alexandra Valsamakis, Annette M. Jackson, John R. Ticehurst, Robert A. Montgomery, Kathleen B. Schwarz, Kenrad E. Nelson, Wikrom Karnsakul

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background. Autochthonous hepatitis E virus (HEV) infection has been reported in over 200 solid organ transplant (SOT) recipients since 2006, yet little is known about the burden of HEV among SOT recipients in North America. We performed a retrospective, cross-sectional study to investigate the prevalence and risk factors associated with HEV infection among SOT recipients at our institution. Methods. Children and adults (n = 311) who received allografts between 1988 and 2012 at the Johns Hopkins Hospital were assessed for evidence of HEV infection by testing posttransplantation serum samples for HEV antibody by enzyme immunoassay and HEV RNA by reverse transcription quantitative polymerase chain reaction. Individuals with evidence of posttransplant HEV infection (presence of anti-HEV immunoglobulin [Ig]M antibody, anti-HEV IgG seroconversion, or HEV RNA) were compared with individuals without evidence of infection and assessed for risk factors associated with infection. Results. Twelve individuals (4%) developed posttransplant HEV infection. Posttransplant HEV infection was associated with an increased risk for graft rejection (odds ratio, 14.2; P = .03). No individuals developed chronic infection. Conclusions. Solid organ transplant recipients in the United States are at risk for posttransplant HEV infection. Further studies are needed to characterize environmental risk factors and the risk of HEV infection after SOT in North America.

Original languageEnglish (US)
Article numberofw006
JournalOpen Forum Infectious Diseases
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Hepatitis E virus
Virus Diseases
Transplants
North America
Transplant Recipients
Infection
RNA
Graft Rejection
Immunoenzyme Techniques

Keywords

  • Hepatitis E virus
  • Renal transplantation
  • Solid organ transplantation
  • Viral hepatitis

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Cite this

Sue, P. K., Pisanic, N., Heaney, C. D., Forman, M., Valsamakis, A., Jackson, A. M., ... Karnsakul, W. (2016). Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center. Open Forum Infectious Diseases, 3(1), [ofw006]. https://doi.org/10.1093/ofid/ofw006

Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center. / Sue, Paul K.; Pisanic, Nora; Heaney, Christopher D.; Forman, Michael; Valsamakis, Alexandra; Jackson, Annette M.; Ticehurst, John R.; Montgomery, Robert A.; Schwarz, Kathleen B.; Nelson, Kenrad E.; Karnsakul, Wikrom.

In: Open Forum Infectious Diseases, Vol. 3, No. 1, ofw006, 01.01.2016.

Research output: Contribution to journalArticle

Sue, PK, Pisanic, N, Heaney, CD, Forman, M, Valsamakis, A, Jackson, AM, Ticehurst, JR, Montgomery, RA, Schwarz, KB, Nelson, KE & Karnsakul, W 2016, 'Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center', Open Forum Infectious Diseases, vol. 3, no. 1, ofw006. https://doi.org/10.1093/ofid/ofw006
Sue, Paul K. ; Pisanic, Nora ; Heaney, Christopher D. ; Forman, Michael ; Valsamakis, Alexandra ; Jackson, Annette M. ; Ticehurst, John R. ; Montgomery, Robert A. ; Schwarz, Kathleen B. ; Nelson, Kenrad E. ; Karnsakul, Wikrom. / Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center. In: Open Forum Infectious Diseases. 2016 ; Vol. 3, No. 1.
@article{06d1b132945a4ff69be53b4e6f384a10,
title = "Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center",
abstract = "Background. Autochthonous hepatitis E virus (HEV) infection has been reported in over 200 solid organ transplant (SOT) recipients since 2006, yet little is known about the burden of HEV among SOT recipients in North America. We performed a retrospective, cross-sectional study to investigate the prevalence and risk factors associated with HEV infection among SOT recipients at our institution. Methods. Children and adults (n = 311) who received allografts between 1988 and 2012 at the Johns Hopkins Hospital were assessed for evidence of HEV infection by testing posttransplantation serum samples for HEV antibody by enzyme immunoassay and HEV RNA by reverse transcription quantitative polymerase chain reaction. Individuals with evidence of posttransplant HEV infection (presence of anti-HEV immunoglobulin [Ig]M antibody, anti-HEV IgG seroconversion, or HEV RNA) were compared with individuals without evidence of infection and assessed for risk factors associated with infection. Results. Twelve individuals (4{\%}) developed posttransplant HEV infection. Posttransplant HEV infection was associated with an increased risk for graft rejection (odds ratio, 14.2; P = .03). No individuals developed chronic infection. Conclusions. Solid organ transplant recipients in the United States are at risk for posttransplant HEV infection. Further studies are needed to characterize environmental risk factors and the risk of HEV infection after SOT in North America.",
keywords = "Hepatitis E virus, Renal transplantation, Solid organ transplantation, Viral hepatitis",
author = "Sue, {Paul K.} and Nora Pisanic and Heaney, {Christopher D.} and Michael Forman and Alexandra Valsamakis and Jackson, {Annette M.} and Ticehurst, {John R.} and Montgomery, {Robert A.} and Schwarz, {Kathleen B.} and Nelson, {Kenrad E.} and Wikrom Karnsakul",
year = "2016",
month = "1",
day = "1",
doi = "10.1093/ofid/ofw006",
language = "English (US)",
volume = "3",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center

AU - Sue, Paul K.

AU - Pisanic, Nora

AU - Heaney, Christopher D.

AU - Forman, Michael

AU - Valsamakis, Alexandra

AU - Jackson, Annette M.

AU - Ticehurst, John R.

AU - Montgomery, Robert A.

AU - Schwarz, Kathleen B.

AU - Nelson, Kenrad E.

AU - Karnsakul, Wikrom

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background. Autochthonous hepatitis E virus (HEV) infection has been reported in over 200 solid organ transplant (SOT) recipients since 2006, yet little is known about the burden of HEV among SOT recipients in North America. We performed a retrospective, cross-sectional study to investigate the prevalence and risk factors associated with HEV infection among SOT recipients at our institution. Methods. Children and adults (n = 311) who received allografts between 1988 and 2012 at the Johns Hopkins Hospital were assessed for evidence of HEV infection by testing posttransplantation serum samples for HEV antibody by enzyme immunoassay and HEV RNA by reverse transcription quantitative polymerase chain reaction. Individuals with evidence of posttransplant HEV infection (presence of anti-HEV immunoglobulin [Ig]M antibody, anti-HEV IgG seroconversion, or HEV RNA) were compared with individuals without evidence of infection and assessed for risk factors associated with infection. Results. Twelve individuals (4%) developed posttransplant HEV infection. Posttransplant HEV infection was associated with an increased risk for graft rejection (odds ratio, 14.2; P = .03). No individuals developed chronic infection. Conclusions. Solid organ transplant recipients in the United States are at risk for posttransplant HEV infection. Further studies are needed to characterize environmental risk factors and the risk of HEV infection after SOT in North America.

AB - Background. Autochthonous hepatitis E virus (HEV) infection has been reported in over 200 solid organ transplant (SOT) recipients since 2006, yet little is known about the burden of HEV among SOT recipients in North America. We performed a retrospective, cross-sectional study to investigate the prevalence and risk factors associated with HEV infection among SOT recipients at our institution. Methods. Children and adults (n = 311) who received allografts between 1988 and 2012 at the Johns Hopkins Hospital were assessed for evidence of HEV infection by testing posttransplantation serum samples for HEV antibody by enzyme immunoassay and HEV RNA by reverse transcription quantitative polymerase chain reaction. Individuals with evidence of posttransplant HEV infection (presence of anti-HEV immunoglobulin [Ig]M antibody, anti-HEV IgG seroconversion, or HEV RNA) were compared with individuals without evidence of infection and assessed for risk factors associated with infection. Results. Twelve individuals (4%) developed posttransplant HEV infection. Posttransplant HEV infection was associated with an increased risk for graft rejection (odds ratio, 14.2; P = .03). No individuals developed chronic infection. Conclusions. Solid organ transplant recipients in the United States are at risk for posttransplant HEV infection. Further studies are needed to characterize environmental risk factors and the risk of HEV infection after SOT in North America.

KW - Hepatitis E virus

KW - Renal transplantation

KW - Solid organ transplantation

KW - Viral hepatitis

UR - http://www.scopus.com/inward/record.url?scp=85000542449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000542449&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofw006

DO - 10.1093/ofid/ofw006

M3 - Article

VL - 3

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - 1

M1 - ofw006

ER -